MBX Biosciences Inc’s filing revealed that its Director Mathers Edward T acquired Company’s shares for reported $8.0 million on Sep 16 ’24. In the deal valued at $16.00 per share,500,000 shares were bought. As a result of this transaction, Mathers Edward T now holds 3,614,486 shares worth roughly $73.59 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, BASKETT FOREST bought 500,000 shares, generating $8,000,000 in total proceeds. Upon buying the shares at $16.00, the 10% Owner now owns 3,614,486 shares.
Before that, Behbahani Ali bought 500,000 shares. MBX Biosciences Inc shares valued at $8,000,000 were divested by the 10% Owner at a price of $16.00 per share. As a result of the transaction, Behbahani Ali now holds 3,614,486 shares, worth roughly $73.59 million.
Stifel initiated its MBX Biosciences Inc [MBX] rating to a Buy in a research note published on October 08, 2024; the price target was $40. A number of analysts have revised their coverage, including JP Morgan’s analysts, who began to cover the stock in early October with a ‘”an Overweight”‘ rating. Jefferies began covering MBX with “Buy” recommendation on October 08, 2024. Guggenheim started covering the stock on October 08, 2024. It rated MBX as “a Buy”.
Price Performance Review of MBX
On Friday, MBX Biosciences Inc [NASDAQ:MBX] saw its stock jump 0.44% to $20.36. Over the last five days, the stock has gained 7.50%. MBX Biosciences Inc shares have fallen nearly -13.91% since the year began.
Levels Of Support And Resistance For MBX Stock
The 24-hour chart illustrates a support level at 19.17, which if violated will result in even more drops to 17.97. On the upside, there is a resistance level at 21.60. A further resistance level may holdings at 22.83. The Relative Strength Index (RSI) on the 14-day chart is 50.00, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.41, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 61.15%. Stochastics %K at 33.75% indicates the stock is a holding.
How much short interest is there in MBX Biosciences Inc?
A steep rise in short interest was recorded in MBX Biosciences Inc stocks on 2024-11-29, growing by 0.13 million shares to a total of 0.49 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-31 was 0.35 million shares. There was a rise of 27.71%, which implies that there is a positive sentiment for the stock.
